FIELD: medicine; pharmaceuticals.
SUBSTANCE: described are pharmaceutical compositions containing cefepime or a pharmaceutically acceptable derivative thereof and a compound of formula (I)
or a stereoisomer thereof or a pharmaceutically acceptable derivative thereof.
EFFECT: disclosed are pharmaceutical compositions containing antibacterial agents.
8 cl, 4 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2015 |
|
RU2705375C2 |
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
NITROGEN-CONTAINING COMPOUNDS AND APPLICATION THEREOF | 2012 |
|
RU2569307C1 |
ANTIBACTERIAL COMPOSITIONS AND METHODS | 2017 |
|
RU2779346C2 |
PHARMACEUTICAL COMPOSITIONS, CONTAINING SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2560846C1 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
ANTIBACTERIAL COMPOSITIONS | 2017 |
|
RU2813568C2 |
COMPOSITIONS CONTAINING ANTIBACTERIAL AGENT AND TAZOBACTAM | 2011 |
|
RU2593363C2 |
Authors
Dates
2019-10-08—Published
2014-10-22—Filed